Physician

Maen A Hussein, M.D.

According to 2025 Medicare claims, Maen Hussein, M.D. (NPI: 1356332506) practices hematology/oncology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Lake, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 32159-8984.

Hussein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,085 traditional Medicare patients, billed 538,934 HCPCS/CPT codes, and received $8,530,605 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,033 prescription claims across 611 beneficiaries totaling $11,495,395 in drug costs, led by Revlimid (Lenalidomide). DME data shows 155 claims. Open Payments data shows 316 records totaling $409,020. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,489,052 to $11,495,395. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $15,768 to $4,903.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,733	558,073	$6,132,525
2016	3,013	688,816	$7,353,999
2017	3,409	755,174	$9,103,605
2018	3,259	975,594	$10,431,939
2019	3,180	954,764	$10,939,760
2020	2,908	974,707	$10,489,527
2021	3,001	705,128	$9,532,729
2022	2,218	603,042	$8,630,869
2023	2,077	562,980	$9,048,672
2024	2,085	538,934	$8,530,605

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	595	3,190	$3,489,052
2016	631	3,133	$4,098,598
2017	685	3,092	$4,795,676
2018	711	3,362	$6,467,173
2019	810	3,867	$8,499,147
2020	768	4,264	$10,832,890
2021	749	3,901	$11,295,204
2022	689	3,404	$9,631,070
2023	646	3,187	$9,027,087
2024	611	3,033	$11,495,395

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	85	420	$119,786
2016	64	303	$67,218
2017	48	203	$50,775
2018	69	273	$50,283
2019	78	299	$53,095
2020	83	404	$98,805
2021	47	288	$71,343
2022	13	169	$67,002
2023	49	203	$78,072
2024	18	155	$93,615

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	810	1,725	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,090	2,155	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	654	1,199	$13
36415	Insertion of needle into vein for collection of blood sample	1,515	4,616	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,483	4,851	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	154	4,151	$2,539,656
Imbruvica	Ibrutinib	92	2,710	$991,536
Ibrance	Palbociclib	59	1,645	$945,343
Brukinsa	Zanubrutinib	57	1,710	$830,051
Pomalyst	Pomalidomide	32	896	$728,015

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	24	$86,426
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	18	20	$3,967
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	23	$1,636
J8521	Capecitabine, oral, 500 mg	N	N/R	27	$828
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	14	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	183	$27,444	Ipsen Biopharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	133	$381,577	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Maen A. Hussein, M.D.?

Tedicare shows public-source Medicare data for Maen A. Hussein, M.D. (NPI 1356332506), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Maen A. Hussein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Maen A. Hussein, M.D.?

Maen A. Hussein, M.D. is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Maen A. Hussein, M.D. have Open Payments data?

Maen A. Hussein, M.D. has 316 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.